IL13RA2 and neoplasm: To understand the effect of ICG-001 on tumor metabolism alone and in combination with IL13Rα2–CAR T cells, we established orthotopic immunocompetent mouse models of syngeneic glioma using K-Luc glioma cells and engineered murine IL13Rα2-targeted CAR T cells (51).